At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
COVID-19: Well-Being in Cancer Patients With Neuropathy Who Participated in Prior Clinical Trials
In Brief
An observational study evaluating Quality-of-Life Assessment and Questionnaire Administration for COVID-19 Infection and 3 related conditions. Active but no longer recruiting, targeting 274 participants across 1 site.
Detailed Summary
This study investigates the experiences of cancer patients with neuropathy during the COVID-19 pandemic to learn how the COVID-19 pandemic affects their quality of life and clinical outcomes. This study will also explore whether there are differences between patients who received neurofeedback (NFB, a type of therapy that is thought to help normalize brain activity) and those who did not. Learning about quality of life in cancer patients with neuropathy during the COVID-19 pandemic may help guide development of programs and policies to improve chronic pain patient care and outcomes during a major global healthcare crisis.
Study Details
Timeline
Interventions
Ancillary studies
Complete questionnaire